0001209191-23-047456.txt : 20230825
0001209191-23-047456.hdr.sgml : 20230825
20230825194215
ACCESSION NUMBER: 0001209191-23-047456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230823
FILED AS OF DATE: 20230825
DATE AS OF CHANGE: 20230825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zabrowksi Dan
CENTRAL INDEX KEY: 0001940818
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39488
FILM NUMBER: 231209800
MAIL ADDRESS:
STREET 1: C/O APEXIGEN INC
STREET 2: 75 SHOREWAY ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apexigen, Inc.
CENTRAL INDEX KEY: 0001814140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851260244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650.931.6236
MAIL ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Brookline Capital Acquisition Corp.
DATE OF NAME CHANGE: 20200603
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-23
1
0001814140
Apexigen, Inc.
APGN
0001940818
Zabrowksi Dan
C/O APEXIGEN, INC.
900 INDUSTRIAL ROAD, SUITE C
SAN CARLOS
CA
94070
1
0
0
0
0
Stock Option (right to buy)
2.65
2023-08-23
4
D
0
100000
D
2032-09-29
Common Stock
100000
0
D
The shares subject to the option vest in three equal annual installments beginning on July 29, 2023. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023, by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time.
/s/ Francis Sarena, by power of attorney
2023-08-25